Insider Trading activities of Kalvista Pharmaceuticals, Inc. (KALV)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kalvista Pharmaceuticals, Inc. (KALV) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kalvista Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Kalvista Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is KALV. The reporting company's CIK number is 1348911.
The total value of stock buying since 2005 is $61,266,920.
The total value of stock sales since 2005 is $67,323,858.
The total value of stock option exercises since 2005 is $401,861.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Kalvista Pharmaceuticals, Inc. (KALV).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-04 0 $0 141,400 $3,960,864 15,428 $63,591
2019-03 0 $0 1,000,957 $27,804,713 0 $0
2019-02 0 $0 214,198 $4,401,357 0 $0
2019-01 0 $0 25,854 $490,166 7,355 $28
2018-12 0 $0 31,288 $625,999 0 $0
2018-09 1,117,648 $19,000,016 0 $0 0 $0
2017-10 2,265,065 $19,316,904 2,725,283 $28,659,762 0 $0
2017-09 0 $0 176,647 $1,343,997 0 $0
2016-11 0 $0 0 $0 42,429 $332,642
2015-12 0 $0 10,000 $37,000 10,000 $5,600
2015-04 4,590,000 $22,950,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Kalvista Pharmaceuticals, Inc. insiders (KALV)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-04-22 Yea Christopher (Chief Development Officer) Sale 7,355 26.36 193,841
2019-04-22 Yea Christopher (Chief Development Officer) Option Ex 7,355 .00 29
2019-04-22 Palleiko Benjamin L (CBO, CFO and Secretary) Sale 2,000 25.80 51,604
2019-04-22 Palleiko Benjamin L (CBO, CFO and Secretary) Option Ex 2,000 8.39 16,780
2019-04-18 Palleiko Benjamin L (CBO, CFO and Secretary) Sale 1,073 25.51 27,373
2019-04-18 Palleiko Benjamin L (CBO, CFO and Secretary) Option Ex 1,073 6.74 7,232
2019-04-17 Feener Edward P. (Chief Scientific Officer) Sale 4,000 25.08 100,336
2019-04-15 Crockett Thomas Andrew (CEO) Sale 10,000 25.34 253,420
2019-04-10 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 13,531 29.39 397,743
2019-04-09 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 13,669 28.53 389,990
2019-04-08 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 22,800 29.49 672,417
2019-04-05 Maetzel Andreas (Senior Vice President Medical) Sale 5,000 30.00 150,010
2019-04-05 Maetzel Andreas (Senior Vice President Medical) Option Ex 5,000 7.91 39,550
2019-04-02 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 9,141 28.76 262,931
2019-04-01 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 52,831 27.66 1,461,199
2019-03-29 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 35,102 28.40 996,756
2019-03-28 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 36,665 27.80 1,019,323
2019-03-27 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 57,917 29.06 1,683,010
2019-03-26 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 30,093 29.70 893,701
2019-03-18 Shah Nimish P (10% Owner) Sale 500,000 28.75 14,375,000
2019-03-18 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 262,470 26.70 7,007,949
2019-03-14 Crockett Thomas Andrew (CEO) Sale 3,000 30.16 90,483
2019-03-05 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 32,332 23.04 744,832
2019-03-04 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 43,378 22.91 993,659
2019-02-21 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 172,543 20.60 3,554,385
2019-02-20 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 23,235 20.02 465,071
2019-02-19 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 18,420 20.73 381,901
2019-01-25 Yea Christopher (Chief Development Officer) Sale 5,453 17.06 93,017
2019-01-25 Yea Christopher (Chief Development Officer) Option Ex 5,453 .00 21
2019-01-23 Yea Christopher (Chief Development Officer) Sale 600 17.01 10,204
2019-01-23 Yea Christopher (Chief Development Officer) Option Ex 600 .00 2
2019-01-22 Yea Christopher (Chief Development Officer) Sale 1,302 17.00 22,139
2019-01-22 Yea Christopher (Chief Development Officer) Option Ex 1,302 .00 5
2019-01-16 Feener Edward P. (Chief Scientific Officer) Sale 4,000 19.51 78,024
2019-01-14 Crockett Thomas Andrew (CEO) Sale 10,000 19.57 195,710
2019-01-07 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 2,599 20.41 53,050
2019-01-03 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 1,700 20.01 34,022
2019-01-02 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 200 20.00 4,000
2018-12-31 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 25,418 20.00 508,461
2018-12-28 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 3,734 20.03 74,780
2018-12-19 Sv Life Sciences Fund Iv, L.p. (10% Owner) Sale 2,136 20.02 42,758
2018-09-10 Cha Albert Buy 1,058,824 17.00 18,000,008
2018-09-10 Oronsky Arnold L Buy 58,824 17.00 1,000,008
2017-10-12 Shah Rajeev M. Buy 850,000 8.50 7,225,000
2017-10-12 Novo Holdings A/s (10% Owner) Sale 1,726,481 9.26 15,987,214
2017-10-12 Kolchinsky Peter Buy 850,000 8.50 7,225,000
2017-10-12 Aldrich Richard (Director) Buy 565,065 8.61 4,866,904
2017-10-11 Novo Holdings A/s (10% Owner) Sale 35,519 10.21 362,755
2017-10-10 Novo Holdings A/s (10% Owner) Sale 963,283 12.78 12,309,793
2017-09-15 Novo Holdings A/s (10% Owner) Sale 140,747 7.50 1,055,883
2017-09-14 Novo Holdings A/s (10% Owner) Sale 10,000 8.05 80,500
2017-09-13 Novo Holdings A/s (10% Owner) Sale 25,900 8.02 207,614
2016-11-21 Maroney Marcee (VP, Clinical Affairs) Option Ex 4,664 7.84 36,565
2016-11-21 Renzi David (President & CEO) Option Ex 36,640 7.84 287,257
2016-11-21 Basta Steven L Option Ex 1,125 7.84 8,820
2015-12-30 Renzi David (President & CEO) Sale 10,000 3.70 37,000
2015-12-30 Renzi David (President & CEO) Option Ex 10,000 .56 5,600
2015-04-14 Vivo Ventures Vi Affiilates Fund, L.p. (10% Owner) Buy 1,012,500 5.00 5,062,500
2015-04-14 Cha Albert (Director) Buy 1,012,500 5.00 5,062,500
2015-04-14 Nasr Khaled (10% Owner) Buy 810,000 5.00 4,050,000
2015-04-14 Nohra Guy P (Director) Buy 877,500 5.00 4,387,500
2015-04-14 Janney Daniel (10% Owner) Buy 877,500 5.00 4,387,500

Insider trading activities including stock purchases, stock sales, and option exercises of KALV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kalvista Pharmaceuticals, Inc. (symbol KALV, CIK number 1348911) see the Securities and Exchange Commission (SEC) website.